400-859-2883
Your location:Home >News center >Industry News

Industry News

04-192022

New FDA Approved Drugs in Q1 2022

With the first three months of 2022 now in the rear-view mirror, the FDA has approved 10 new drugs (Table 1).

New FDA Approved Drugs in Q1 2022
04-142022

Ensitrelvir, A Novel Antiviral Drug Again…

In addition to vaccines, oral antiviral drugs are expected to play an important role in the treatment of COVID-19 caused by severe acute respiratory disease coronavirus-2 (SARS-CoV-2) infecti…

Ensitrelvir, A Novel Antiviral Drug Against COVID-19
03-312022

Challenges of Immunotherapy For Prostate …

On March 15, 2022, Merck announced that it would discontinue the KEYLYNK-010 study. Results of interim analysis showed that KEYTRUDA (pembrolizumab) in combination with LYNPARZA (olaparib) fa…

Challenges of Immunotherapy For Prostate Cancer
03-282022

Immunotherapy + mRNA Technology To Treat …

The study found that cancer stem cells in triple-negative breast tumors had low expression of ligand-dependent corepressor (LCOR), which led to their escape from immunotherapy. On this basis,…

Immunotherapy + mRNA Technology To Treat Triple Negative Breast Cancer
03-182022

COVID-19 Drugs: Small Molecules VS. Antib…

Eleven COVID-19 therapeutic drug therapies are currently available globally, including eight injectable drug therapies and three oral drugs,

COVID-19 Drugs: Small Molecules VS. Antibodies
03-042022

Paxlovid and Molnupiravir: What Are The D…

What are the differences between the COVID-19 oral drugs - Paxlovid and Molnupiravir.

Paxlovid and Molnupiravir: What Are The Differences?
02-252022

Top 10 Breakthrough Technologies in 2022,…

On February 23, MIT Technology Review, a world-renowned technology media, announced the "2022 10 Breakthrough Technologies", with 4 from biomedical field. They are not only based on…

Top 10 Breakthrough Technologies in 2022, 4 From Biomedical Field
02-092022

Game Changer? Paxlovid, First Oral Antiv…

FDA granted EUA for Pfizers oral antiviral drug Paxlovid for the treatment of COVID-19, a SARS-CoV-2-3CL protease inhibitor.

Game Changer? Paxlovid, First Oral Antiviral For Covid-19
02-082022

Nanoparticles May Solve Thorny Problem In…

Patients need to receive regular hormone injections through syringes, insulin pumps or other devices. These treatments may be accompanied by life.

Nanoparticles May Solve Thorny Problem In Diabetes Treatment
01-272022

Development of Anti Influenza Drugs: Curr…

Each year, seasonal influenza pandemics can result in 3-5 million severe cases and 290,000-650,000 respiratory disease-related deaths worldwide. So far, there are five documented influenza pa…

Development of Anti Influenza Drugs: Currently Approved And Under Development